US Begins Studying Risk of Allergic Reactions to Moderna, Pfizer COVID-19 Vaccines
(Reuters) – The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc. (Clinicaltrials.gov NCT04761822 https://bit.ly/3dG9JaK)
Source: Read Full Article
